Open original FDA record ↗Recall record
- FDA identifier
- Z-0685-2019
- Company in FDA record
- Hologic, Inc.
- FDA record creation date
- Dec 27, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Calibration issue not possible to visualize contrast uptake in the subtracted mammography images
Source facts
- Action
- Hologic issued letter on 12/6/2018 USPS Certified Mail to customers to inform them of this product correction, and Hologic asks customers to only use I-View for patients with known lesions and confirm the image quality is of acceptable diagnostic quality.Hologic will scheduling appointments to recalibrate the systems for contrast enhanced digital mammography.
- Initiated
- 2018-12-06
- Root cause
- Software design
- Terminated
- 2020-04-24
- Distribution
- Nationwide Foreign: Australia Austria Belgium Brazil Canada China Colombia Ecuador Egypt France Germany Greece Hong Kong India Ireland Israel Italy Japan Korea, Republic of Kuwait Malaysia Mexico Netherlands Pakistan Peru Poland Portugal Saudi Arabia Singapore Slovakia South Africa Spain Switzerland Switzerland Taiwan Thailand Turkey United Arab Emirates United Kingdom
- Recall number
- Z-0685-2019
- Recall status
- Terminated
- CDRH record ID
- 169573
- FDA record created
- 2018-12-27
- Recall event number
- 81700